SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 194 filers reported holding SAGE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.43 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,997 | +4148.9% | 97 | +9600.0% | 0.00% | – |
| Q2 2023 | $47 | +11.9% | 1 | 0.0% | 0.00% | – |
| Q1 2023 | $42 | +10.5% | 1 | 0.0% | 0.00% | – |
| Q4 2022 | $38 | – | 1 | 0.0% | 0.00% | – |
| Q3 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q2 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 1 | -99.5% | 0.00% | – |
| Q2 2021 | $12,000 | 0.0% | 205 | +32.3% | 0.00% | – |
| Q1 2021 | $12,000 | +33.3% | 155 | +24.0% | 0.00% | – |
| Q4 2019 | $9,000 | +350.0% | 125 | +733.3% | 0.00% | – |
| Q2 2018 | $2,000 | – | 15 | +66.7% | 0.00% | – |
| Q3 2016 | $0 | – | 9 | 0.0% | 0.00% | – |
| Q2 2016 | $0 | – | 9 | -30.8% | 0.00% | – |
| Q1 2016 | $0 | -100.0% | 13 | -94.0% | 0.00% | – |
| Q4 2015 | $13,000 | – | 218 | +3014.3% | 0.00% | – |
| Q3 2015 | $0 | – | 7 | -46.2% | 0.00% | – |
| Q2 2015 | $0 | – | 13 | 0.0% | 0.00% | – |
| Q1 2015 | $0 | – | 13 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Integral Health Asset Management, LLC | 311,000 | $10,294,000 | 2.68% |
| Palo Alto Investors LP | 851,719 | $28,192,000 | 2.18% |
| Boxer Capital, LLC | 1,094,000 | $36,211,000 | 1.86% |
| DAFNA Capital Management LLC | 180,306 | $5,968,000 | 1.56% |
| Deep Track Capital, LP | 675,000 | $22,343,000 | 1.43% |
| Bellevue Group AG | 3,052,404 | $101,034,000 | 1.17% |
| Ikarian Capital, LLC | 249,907 | $8,272,000 | 1.09% |
| Ikarian Capital, LLC | 250,000 | $8,275,000 | 1.09% |
| Artal Group S.A. | 750,000 | $24,825,000 | 1.04% |
| SECTOR GAMMA AS | 118,476 | $3,922,000 | 0.85% |